Leidos to Help USAID Facilitate Malaria Vaccine R&D Projects; Jerry Hogge Comments

LeidosLogoLeidos (NYSE: LDOS) has been awarded a potential five-year, $23.7 million contract to support the U.S. Agency for International Development‘s efforts to research and develop a vaccine against malaria.

The company said Monday it will provide scientific and management services for USAID’s Malaria Vaccine Development Program under the cost-plus-fixed-fee contract.

Jerry Hogge, Leidos health deputy group president, said the company brings decades of life sciences technology and experience to the USAID program.

Leidos said the work to occur in Frederick, Maryland, could also evaluate malaria vaccine candidates during preclinical studies and clinical and field trials.

The company’s life sciences team supports medical product R&D efforts at the National Institutes of Health and the departments of Defense and Homeland Security.

Check Also

fuel supply

DLA Selects 10 Awardees for Fuel Supply IDIQs 

Ten companies have each received indefinite-delivery/indefinite-quantity contracts to provide various fuel types to support designated Defense Logistics Agency missions.

BAE Systems

BAE Closes Purchase of Collins Aerospace’s Military GPS Business

BAE Systems has finalized its acquisition of the military GPS business of Raytheon Technologies’ (NYSE: RTX) Collins Aerospace subsidiary. BAE agreed to buy the military GPS business for $1.925B in cash in January and expects the transaction to expand its existing portfolio of electronics systems, the company said Friday.